This company has been marked as potentially delisted and may not be actively trading. Keryx Biopharmaceuticals (KERX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock KERX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period LBTI Lithium & Boron Technology, Inc.September 24, 2024 | seekingalpha.com2024 Biopharmaceutical Industry LandscapeAugust 17, 2024 | morningstar.comMCaliway Biopharmaceuticals Co Ltd 6919April 13, 2024 | morningstar.comMXTL Biopharmaceuticals Ltd ADR XTLBNovember 15, 2023 | morningstar.comMImmuneOnco Biopharmaceuticals Shanghai Inc (1541)September 11, 2023 | investing.comQ2 2023 Westrock Coffee Co Earnings CallAugust 13, 2023 | finance.yahoo.comKeryx CEO vs. a Short-Seller: Zerenex Patent DebateJuly 29, 2023 | thestreet.com8-K: CUTERA INCMay 11, 2023 | marketwatch.comManoj MadhavanMay 6, 2023 | seekingalpha.comBiopharmaceuticals Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and ForecastMay 3, 2023 | finance.yahoo.comStaidson (Beijing) Biopharmaceuticals Co. Ltd.April 13, 2023 | wsj.comBiopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight PartnersMarch 28, 2023 | finance.yahoo.comBiopharmaceuticals Market 2023 Analysis by Market Size, New Technology, Growth Rate, Geographical Regions, Drivers and Outlook to 2027January 29, 2023 | marketwatch.comNAVB Navidea Biopharmaceuticals, Inc.January 25, 2023 | seekingalpha.comBiopharmaceuticals Contract Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)January 25, 2023 | finance.yahoo.comWell-Fed Analysts Stay Mum on Keryx Biopharma's Slow Drug LaunchSeptember 15, 2022 | thestreet.comKeryx (KERX) Q1 Loss Wider than Expected, Revenues BeatOctober 26, 2021 | finance.yahoo.comTwitter tests notification banner for suspended and locked accountsJuly 29, 2021 | au.finance.yahoo.comJoey Jordison, Slipknot co-founder and longtime drummer, dies at age 46July 29, 2021 | yahoo.comWhy Starbucks (SBUX) Might Surprise This Earnings SeasonJuly 28, 2021 | uk.finance.yahoo.comUN: World leaders can attend annual UN meeting in personJuly 27, 2021 | uk.finance.yahoo.comCreekstone Farms Meats Sizzle on Yoder Smokers With New PartnershipJuly 27, 2021 | nz.finance.yahoo.comMidtown, Atlanta Based Innovien Solutions Continues Growth StreakJuly 27, 2021 | au.finance.yahoo.comJill Biden Made This Versatile Bag Sell Out, and She Just Wore It AgainJuly 27, 2021 | nz.finance.yahoo.comIt's Your Business | More improvements on tap for Target on North ProspectJuly 27, 2021 | yahoo.com Get Keryx Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KERX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KERX Media Mentions By Week KERX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KERX News Sentiment▼0.001.04▲Average Medical News Sentiment KERX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KERX Articles This Week▼00▲KERX Articles Average Week Get the Latest News and Ratings for KERX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Keryx Biopharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Innoviva News OPKO Health News Dynavax Technologies News Geron News Zenas BioPharma News Myriad Genetics News Rigel Pharmaceuticals News Verastem News XOMA Royalty News Lexicon Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KERX) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keryx Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keryx Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KERX Stock Alerts